Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Researchers Develop Blockchain Protocol to Prevent Counterfeit Pharmaceutical Sales

By Portland State University | April 17, 2019

Portland State University researcher Nirupama Bulusu wants to prevent counterfeit pharmaceuticals from flooding the market. Bulusu recently published a blockchain protocol that could do just that.

Bulusu, professor of computer science at the Maseeh College of Engineering and Computer Science, worked with PSU computer science doctoral student Naif Alzahrani to publish “A new product anti-counterfeiting blockchain using a truly decentralized dynamic consensus protocol” in the journal Concurrency and Computation: Practice and Experience.

Their approach relies on blockchain to record transactions in a new, more secure, way that would help curb fake pharmaceuticals by product checking and decentralization.

Blockchain stores transactional records each step of the way, creating a chain of information. Only users with a specific key can add or modify the stored information. The PSU protocol allows sellers to track and verify products without relying on centralized systems vulnerable to attack.

Bulusu said she wanted to create the protocol because the counterfeit pharmaceutical crisis harms the most vulnerable international populations.

“We wanted to come up with something that’s foolproof,” she said.

They’ve coupled the protocol with digital product tags that include the product’s serial number, expiration date and name.

Most anti-counterfeit systems at the moment are centralized, which makes it easier for humans and machines to pass off fake goods.

“This protocol could potentially disrupt and disable illicit supply networks,” Bulusu said.

Their protocol could in theory be applied to any supply chain—big or small.

Niche companies worried about trademark violations, for example, could benefit from the protocol. Bulusu said business owners could even verify their product history and track items step by step on their cell phone.

That’s one benefit of blockchain, she added is that the information is harder to fake and modify, making it easier to verify authenticity.

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE